APA (7th ed.) Citation

LP, d. S. F., RA, d. S., NRLL, J., A, d. S. A., JS, A., RR, V., . . . CD, G. (2026). Annexin A1 and its N-terminal peptide Ac2-26 regulate dopaminergic degeneration and neuroinflammation in a 6-OHDA model of Parkinson's disease. Neuropharmacology, 292, 110942. https://doi.org/10.1016/j.neuropharm.2026.110942

Chicago Style (17th ed.) Citation

LP, de Souza Ferreira, et al. "Annexin A1 and Its N-terminal Peptide Ac2-26 Regulate Dopaminergic Degeneration and Neuroinflammation in a 6-OHDA Model of Parkinson's Disease." Neuropharmacology 292 (2026): 110942. https://doi.org/10.1016/j.neuropharm.2026.110942.

MLA (9th ed.) Citation

LP, de Souza Ferreira, et al. "Annexin A1 and Its N-terminal Peptide Ac2-26 Regulate Dopaminergic Degeneration and Neuroinflammation in a 6-OHDA Model of Parkinson's Disease." Neuropharmacology, vol. 292, 2026, p. 110942, https://doi.org/10.1016/j.neuropharm.2026.110942.